Osaic Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60.3K Sell
2,876
-240
-8% -$5.4K ﹤0.01% 5064
2025
Q4
$71.7K Sell
3,116
-2,879
-48% -$94.7K ﹤0.01% 4984
2025
Q3
$180K Buy
5,995
+1,255
+26% +$37.6K ﹤0.01% 4306
2025
Q2
$172K Buy
4,740
+4,634
+4,372% +$167K ﹤0.01% 4062
2025
Q1
$3.84K Sell
106
-391
-79% -$16.3K ﹤0.01% 6310
2024
Q4
$15.6K Buy
497
+170
+52% +$8.43K ﹤0.01% 5512
2024
Q3
$18.2K Sell
327
-160
-33% -$8.15K ﹤0.01% 5442
2024
Q2
$20K Sell
487
-317
-39% -$13.5K ﹤0.01% 5342
2024
Q1
$37.5K Sell
804
-4,024
-83% -$190K ﹤0.01% 4941
2023
Q4
$231K Sell
4,828
-2,591
-35% -$100K ﹤0.01% 3799
2023
Q3
$264K Sell
7,419
-159
-2% -$6.3K ﹤0.01% 3785
2023
Q2
$349K Buy
7,578
+1,982
+35% +$91.9K ﹤0.01% 3459
2023
Q1
$224K Buy
5,596
+688
+14% +$29.5K ﹤0.01% 3778
2022
Q4
$229K Buy
4,908
+1,018
+26% +$40K ﹤0.01% 3728
2022
Q3
$162K Buy
3,890
+1,000
+35% +$51.4K ﹤0.01% 3945
2022
Q2
$171K Buy
2,890
+75
+3% +$4.62K ﹤0.01% 3943
2022
Q1
$198K Sell
2,815
-15
-0.5% -$1.04K ﹤0.01% 4039
2021
Q4
$236K Buy
2,830
+1,218
+76% +$99.1K ﹤0.01% 3796
2021
Q3
$146K Buy
1,612
+339
+27% +$30.6K ﹤0.01% 4204
2021
Q2
$122K Sell
1,273
-1,401
-52% -$146K ﹤0.01% 4311
2021
Q1
$306K Buy
2,674
+852
+47% +$116K ﹤0.01% 3360
2020
Q4
$253K Buy
1,822
+248
+16% +$29.4K ﹤0.01% 3261
2020
Q3
$128K Buy
1,574
+418
+36% +$34.6K ﹤0.01% 3616
2020
Q2
$90K Buy
1,156
+197
+21% +$13K ﹤0.01% 3759
2020
Q1
$43K Buy
+959
New +$49.8K ﹤0.01% 4081

Other funds holding RARE